Precision psychiatry

We pioneer precision psychiatry through biomarker identification for personalized antidepressant development and therapy selection, enhancing treatment outcomes and improving clinical trials.

WORK WITH US

Our focus is depression

We address the low success rates of depression clinical trials by leveraging machine learning and deep learning to analyze EEG data, significantly improving the potential for successful outcomes.

LEARN MORE

300,000,000

Number of people suffering from depression worldwide

#1 cause of death

For individuals aged 15-44 in the U.S.

$1 trillion

Lost productivity every year, worldwide

Brainify.AI CEO, Mariam Khayretdinova, presents latest results at MIT

Apr 17, 2024 9:30:00 AM 1 min read

Brainify.AI Welcomes Dr. Jim Doherty as New Advisory Board Member

Apr 16, 2024 7:28:04 PM 1 min read

Brainify.AI CEO to Pitch at HBS Healthcare Alumni Startup Showcase

Apr 16, 2024 2:31:13 PM 1 min read

Mariam Khayretdinova

Founder & CEO

ALM in Psychology (Harvard), MS in Applied Mathematics with 10 years of experience in tech

Ivan Mishanin

Co-founder & COO

Entrepreneur with 20 years of experience in tech. He sold a previous startup to Zurich Insurance

Alex Shovkun, Ph.D.

Chief AI Officer

Data scientist, Kaggle master, with 15 years of experience in mathematical modeling, including those for diagnostic medical solutions

Andrey Kiryasov,
Kaggle Grand Master

Senior Data Scientist

Data scientist with 20+ years of experience in signals and images classification, detection and segmentation using deep learning methods